Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Cancer Epidemiol. 2016 Sep 26;45:26–31. doi: 10.1016/j.canep.2016.09.003

Table 4.

Cancers identified by active follow-up and by registries by cancer type

Cancer Type Total cancers identified Ratio (times 100) of RG-identified to AF-identified AF-identified as % of total cancers RG-identified as % of total cancers % Exact Histology Match 1
Bladder 624 89.5 (85.1–93.8) 90.4 80.9 70
Brain 175 100.0 (91.0–110.1) 84.2 84.2 89
Breast 2078 99.6 (97.3–102.0) 88.8 88.5 83
Colorectal 1373 102.8 (99.5–106.3) 84.4 86.7 76
Endometrium 437 99.5 (93.8–105.2) 86.3 85.8 70
Esophagous 173 100.7 (92.5–109.0) 87.9 88.4 86
Leukemia 648 114.6 (106.2–124.2) 68.7 78.7 63
Lymphoma 749 95.1 (90.6–99.8) 85.2 81.0 52
Kidney 480 97.6 (91.9–103.0) 85.8 83.8 53
Liver 186 107.9 (98.8–119.0) 81.2 86.7 86
Lung 2056 93.3 (91.1–95.4) 92.1 85.9 68
Melanoma 628 104.1 (97.3–111.6) 74.5 77.5 70
Multiple Myeloma 242 89.7 (82.0–97.5) 88.0 78.9 94
Ovary 252 92.4 (84.9–100.0) 88.5 81.7 65
Oral cavity 377 104.3 (96.5–112.3) 79.8 83.3 82
Pancreas 491 95.1 (90.2–100.2) 88.0 83.7 75
Prostate 4526 88.9 (87.5–90.3) 92.8 82.5 95
Stomach 230 107.4 (98.5–117.1) 82.2 88.3 67
Thyroid 177 104.4 (92.3–118.8) 76.8 80.2 46

AF-identified: ascertained by active follow-up; RG-identified: ascertained by registry linkage.

1

Exact match on four digit ICDO morphology code for jointly-identified cancers.

Note: All cancer types with at least 100 cases are included in the table.